Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin
- 1 August 2005
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 39 (3) , 403-411
- https://doi.org/10.1016/j.freeradbiomed.2005.03.029
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different MechanismsJournal of Biological Chemistry, 2004
- Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cellsNature Immunology, 2002
- Distinct Modes of Cell Death Induced by Different Reactive Oxygen SpeciesPublished by Elsevier ,2002
- The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in ratsPharmacological Research, 2001
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- DexrazoxaneDrugs, 1998
- Effect of Concentration on the Cytotoxic Mechanism of Doxorubicin—Apoptosis and Oxidative DNA DamageBiochemical and Biophysical Research Communications, 1997
- Iron deprivation decreases ribonucleotide reductase activity and DNA synthesisLife Sciences, 1992
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988